A.I. BURNASYAN FMBC CLINICAL BULLETIN

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №2 2025 год

more

A.I. Burnasyan  FMBC clinical bulletin. 2025 № 2

N.V. Rylova, N.V. Aksenova

Changes in the Activity of the Cardiovascular System Against the Background of Intense Physical Exertion

International Office, State Research Center – Burnasyan Federal Medical Biophysical Center  of Federal Medical Biological Agency, Moscow, Russiа

Contact person: Rylova Natal’ya Victorovna: rilovanv@mail.ru

Abstract
Purpose: to provide up-to-date data on the life expectancy of athletes, as well as to study the effect of intense physical activity on the cardiovascular system of an athlete.

Material and methods: tte data of domestic and foreign literature on the impact of professional sports on the cardiovascular system and life expectancy of athletes were analyzed. The search was carried out using electronic databases MEDLINE, Embase, Scopus, Web of Science, eLIBRARY, PubMed and Google Academy for the period from 2014 to 2024. For the search, we used keywords and their combinations: “physical activity”, “athletes”, “cardiovascular diseases”.

Results: despite reports of the dangers of excessive physical activity on the human body, recent evidence suggests that professional athletes, on average, live longer than non-athletes. At the same time, intensive sports activities are associated with significant changes in the activity of the cardiovascular system. It has been shown that athletes involved in endurance sports have an increased incidence of arrhythmia and conduction disorders (atrial fibrillation, ventricular tachycardia, atrioventricular blockade, QT prolongation, etc.). In addition, professional athletes are more likely to develop structural changes in the heart. There is evidence that athletes involved in strength and team sports have higher blood pressure levels and more often suffer from prehypertension and hypertension than athletes in aerobic disciplines. Also, athletes of strength sports have an increased risk of developing aortic dilatation, which can lead to aortic regurgitation.

Keywords: physical activity, athletes, cardiovascular disease

For citation: Rylova NV, Aksenova NV.C hanges in the Activity of the Cardiovascular System Against the Background of Intense Physical Exertion. A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2025.2:40-45. (In Russian) DOI: 10.33266/2782-6430-2025-2-40-45

 

REFERENCES

  1. Nystoriak M.A., Bhatnagar A. Cardiovascular Effects and Benefits of Exercise. Front Cardiovasc Med. 2018;5:135. doi: 10.3389/fcvm.2018.00135.
  2. Al-Mallah M.H., Sakr S., Al-Qunaibet A. Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update. Curr Atheroscler Rep. 2018;20;1:1. doi: 10.1007/s11883-018-0711-4.
  3. Laukkanen J.A., Pukkala E., Rauramaa R., Mäkikallio T.H., Toriola A.T., Kurl S. Cardiorespiratory Fitness, Lifestyle Factors and Cancer Risk and Mortality in Finnish Men. Eur J Cancer. 2010;46;2:355-63. doi: 10.1016/j.ejca.2009.07.013.
  4. Li Y., Pan A., Wang D.D., et al. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018;138;4:345–355. doi: 10.1161/CIRCULATIONAHA.117.032047.
  5. Paffenbarger R.S., Hyde R.T., Wing A.L., Hsieh C.C. Physical Activity, All-Cause Mortality, and Longevity of College Alumni. The New England Journal of Medicine. 1986;314;10:605–613.
  6. Franklin B.A., Thompson P.D., Al-Zaiti S.S., et al. Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks into Perspective-An Update: a Scientific Statement from the American Heart Association. Circulation. 2020;141;13:e705-e736. doi: 10.1161/CIR.0000000000000749.
  7. Mohlenkamp S., Lehman N., Breuckmann F. Running the Risk of Coronary Events: Prevalence and Prognostic Relevance of Coronary Atherosclerosis in Marathon Runners. Eur Heart J. 2008;29;15:1903–1910. doi: 10.1093/eurheartj/ehn163.
  8. Schnohr P., O’Keefe J.H., Marott J.L., Lange P., Jensen G.B. Dose of Jogging and Long-Term Mortality: the Copenhagen City Heart Study. J Am Coll Cardiol. 2015;65;5:411-419. doi: 10.1016/j.jacc.2014.11.023.
  9. Antero J., Tanaka H., De Larochelambert Q., Pohar-Perme M., Toussaint J.F. Female and Male US Olympic Athletes Live 5 Years Longer than their General Population Counterparts: a Study of 8124 Former US Olympians. Br J Sports Med. 2021;55;4:206-212. doi: 10.1136/bjsports-2019-101696.
  10. Garatachea N., et al. Elite Athletes Live Longer than the General Population: a Meta-Analysis. Mayo Clin Proc. 2014;89;9:1195–1200. doi: 10.1016/j.mayocp.2014.06.004.
  11. Attard S.M., et al. Longitudinal Trajectories of BMI and Cardiovascular Disease Risk: the National Longitudinal Study of Adolescent Health. Obesity. 2013;21;11:2180–2188. doi: 10.1002/oby.20569.
  12. Rosin B. Is Marathon Running Toxic? An Observational Study of Cardiovascular Disease Prevalence and Longevity in 54 Male Marathon Runners. Phys Sportsmed. 2017;45;2:105–109. doi: 10.1080/00913847.2017.1288545.
  13. Schweiger V., Niederseer D., Schmied C., Attenhofer-Jost C., Caselli S. Athletes and Hypertension. Curr Cardiol Rep. 2021;23;12:176. doi: 10.1007/s11886-021-01608-x.
  14. Hedman K., Moneghetti K.J., Christle J.W., et al. Blood Pressure in Athletic Preparticipation Evaluation and the Implication for Cardiac Remodeling. Heart. 2019;105:1223–1230. doi: 10.1136/heartjnl-2019-314815.
  15. Sharma S., Drezner J.A., Baggish A., et al. International Recommendations for Electrocardiographic Interpretation in Athletes. Eur Heart J. 2018;39;16:1466–1480. doi: 10.1093/eurheartj/ehw631.
  16. O’Keefe E.L., Torres-Acosta N., O’Keefe J.H., Lavie C.J. Training for Longevity: The Reverse J-Curve for Exercise. Mo Med. 2020;117;4:355-361.
  17. Ricci C., Gervasi F., Gaeta M., Smuts C.M., Schutte A.E., Leitzmann M.F. Physical Activity Volume in Relation to Risk of Atrial Fibrillation. A Non-Linear Meta-Regression Analysis. Eur J Prev Cardiol. 2018;25;8:857–866. doi: 10.1177/2047487318768026.
  18. Baldesberger S., Bauersfeld U., Candinas R., et al. Sinus Node Disease and Arrhythmias in the Long-Term Follow-Up of Former Professional Cyclists. Eur Heart J. 2008;29;1:71–78. doi: 10.1093/eurheartj/ehm555.
  19. Graziano F., Juhasz V., Brunetti G., Cipriani A., Szabo L., Merkely B., Corrado D., D’Ascenzi F., Vago H., Zorzi A. May Strenuous Endurance Sports Activity Damage the Cardiovascular System of Healthy Athletes? A Narrative Review. J Cardiovasc Dev Dis. 2022;9;10:347. doi: 10.3390/jcdd9100347.
  20. Zadvorev S.F., Krysiuk O.B., Obrezan A.G., Yakovlev A.A. The Influence of Personal History of Athletic Activity on Clinical Course of Cardiovascular Diseases in Former Athletes. Adv Gerontol. 2018;31:531–537.
  21. Dagradi F., Spazzolini C., Castelletti S., Pedrazzini M., Kotta M.-C., Crotti L., Schwartz P.J. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome. Circulation. 2020;142:2405–2415. doi: 10.1161/CIRCULATIONAHA.120.048916.
  22. La Gerche A. Exercise-Induced Arrhythmogenic (Right Ventricular) Cardiomyopathy is Real…if you Consider it. JACC Cardiovasc Imaging. 2021;14:159–161. doi: 10.1016/j.jcmg.2020.09.014.
  23. Sawant A.C., Bhonsale A., te Riele A.S.J.M., Tichnell C., Murray B., Russell S.D., Tandri H., Tedford R.J., Judge D.P., Calkins H., et al. Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients without Desmosomal Mutations. J Am Heart Assoc. 2014;3:e001471. doi: 10.1161/JAHA.114.001471.
  24. Leischik R., Dworrak B., Strauss M., Horlitz M., Pareja-Galeano H., de la Guía-Galipienso F., Lippi G., Lavie C.J., Perez M.V., Sanchis-Gomar F. Special Article-Exercise-Induced Right Ventricular Injury or Arrhythmogenic Cardiomyopathy (ACM): The Bright Side and the Dark Side of the Moon. Prog Cardiovasc Dis. 2020;63:671–681. doi: 10.1016/j.pcad.2020.03.015.
  25. van de Schoor F.R., Aengevaeren V.L., Hopman M.T., et al. Myocardial Fibrosis in Athletes. Mayo Clin Proc. 2016;91;11:1617–1631. doi: 10.1016/j.mayocp.2016.07.012.
  26. Eijsvogels T.M.H., Oxborough D.L., O’Hanlon R., et al. Global and Regional Cardiac Function in Lifelong Endurance Athletes with and without Myocardial Fibrosis. Eur J Sport Sci. 2017;17;10:1297–1303. doi: 10.1080/17461391.2017.1373864.
  27. Keaney L.C., Kilding A.E., Merien F., Dulson D.K. The Impact of Sport Related Stressors on Immunity and Illness Risk in Team-Sport Athletes. J Sci Med Sport. 2018;21:1192–1199. doi: 10.1016/j.jsams.2018.05.014.
  28. Bouchau R., Cariou E., Deney A., Belaid S., Itier R., Blanchard V., Fournier P., Duparc A., Galinier M., Carrié D., et al. Sports Participation and Myocarditis: Influence of Sport Types on Disease Severity. Int J Cardiol Heart Vasc. 2021;37:100895. doi: 10.1016/j.ijcha.2021.100895.
  29. DeFina L.F., Radford N.B., Barlow C.E., et al. Association of All-Cause and Cardiovascular Mortality with High Levels of Physical Activity and Concurrent Coronary Artery Calcification. JAMA Cardiol. 2019;4;2:174–181. doi: 10.1001/jamacardio.2018.4628.
  30. Merghani A., Maestrini V., Rosmini S., et al. Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes with a Low Atherosclerotic Risk Profile. Circulation. 2017;136;2:126–137. doi: 10.1161/CIRCULATIONAHA.116.026964.
  31. Churchill T.W., Groezinger E., Kim J.H., Loomer G., Guseh J.S., Wasfy M.M., Isselbacher E.M., Lewis G.D., Weiner R.B., Schmied C., et al. Association of Ascending Aortic Dilatation and Long-Term Endurance Exercise among Older Masters-Level Athletes. JAMA Cardiol. 2020;5:522–531. doi: 10.1001/jamacardio.2020.0054.
  32. Kay S., Moore B.M., Moore L., Seco M., Barnes C., Marshman D., Grieve S.M., Celermajer D.S. Rugby Player’s Aorta: Alarming Prevalence of Ascending Aortic Dilatation and Effacement in Elite Rugby Players. Heart Lung Circ. 2020;29:196–201. doi: 10.1016/j.hlc.2019.06.714.

Conflict of interest. The authors declare no conflict of interest. 
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 11.01.2025. Accepted for publication: 15.02.2025

© 2025 Scientific journal - "Clinical Bulletin of the FMBС im. A.I. Burnasyan"
Scroll to Top